These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 3151755
1. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease). Castro JA, Diaz de Toranzo EG. Biomed Environ Sci; 1988 Jun; 1(1):19-33. PubMed ID: 3151755 [Abstract] [Full Text] [Related]
2. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Castro JA, de Mecca MM, Bartel LC. Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919 [Abstract] [Full Text] [Related]
3. Ultrastructural alterations in ovaries from nifurtimox or benznidazole-treated rats: their relation to ovarian nitroreductive biotransformation of both drugs. de Castro CR, de Toranzo EG, Bernacchi AS, Carbone M, Castro JA. Exp Mol Pathol; 1989 Jun; 50(3):385-97. PubMed ID: 2721655 [Abstract] [Full Text] [Related]
4. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial. Villar JC, Herrera VM, Pérez Carreño JG, Váquiro Herrera E, Castellanos Domínguez YZ, Vásquez SM, Cucunubá ZM, Prado NG, Hernández Y. Trials; 2019 Jul 15; 20(1):431. PubMed ID: 31307503 [Abstract] [Full Text] [Related]
5. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children]. Moya PR, Trombotto GT. Medicina (B Aires); 1988 Jul 15; 48(5):487-91. PubMed ID: 3151216 [No Abstract] [Full Text] [Related]
6. Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease treatment. Mazzeti AL, Gonçalves KR, Mota SLA, Pereira DE, Diniz LF, Bahia MT. Parasitology; 2021 Sep 15; 148(11):1320-1327. PubMed ID: 34247670 [Abstract] [Full Text] [Related]
7. Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report. Alarcón de Noya B, Ruiz-Guevara R, Noya O, Castro J, Ossenkopp J, Díaz-Bello Z, Colmenares C, Suárez JA, Noya-Alarcón O, Naranjo L, Gutiérrez H, Quinci G, Torres J. Expert Rev Anti Infect Ther; 2017 Mar 15; 15(3):319-325. PubMed ID: 28132566 [Abstract] [Full Text] [Related]
9. Experimental and Clinical Treatment of Chagas Disease: A Review. Sales Junior PA, Molina I, Fonseca Murta SM, Sánchez-Montalvá A, Salvador F, Corrêa-Oliveira R, Carneiro CM. Am J Trop Med Hyg; 2017 Nov 15; 97(5):1289-1303. PubMed ID: 29016289 [Abstract] [Full Text] [Related]
10. [Possibility of treatment in Chagas' disease]. Prata A. AMB Rev Assoc Med Bras; 1978 Apr 15; 24(4):140-2. PubMed ID: 98813 [No Abstract] [Full Text] [Related]
11. Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects. Mecca MM, Bartel LC, Castro CR, Castro JA. Mem Inst Oswaldo Cruz; 2008 Sep 15; 103(6):549-53. PubMed ID: 18949324 [Abstract] [Full Text] [Related]
12. Species and sex differences in the liver microsomal nitroreductive biotransformation of nifurtimox and benznidazole. Aguilar EG, Koldobsky C, de Toranzo EG, Castro JA. Arch Int Pharmacodyn Ther; 1987 Jun 15; 287(2):181-7. PubMed ID: 3632141 [Abstract] [Full Text] [Related]
13. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection. Gulin JEN, Bisio M, Rocco DM, Altcheh J, Solana ME, García-Bournissen F. Exp Parasitol; 2018 Mar 15; 186():50-58. PubMed ID: 29448038 [Abstract] [Full Text] [Related]
14. Effects of nifurtimox or benznidazole administration on rat testes: ultrastructural observations and biochemical studies. Bernacchi AS, de Castro CR, de Toranzo EG, Castro JA. Exp Mol Pathol; 1986 Dec 15; 45(3):245-56. PubMed ID: 3792509 [Abstract] [Full Text] [Related]
15. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]. Coura JR, de Abreu LL, Willcox HP, Petana W. Rev Soc Bras Med Trop; 1997 Dec 15; 30(2):139-44. PubMed ID: 9148337 [Abstract] [Full Text] [Related]
16. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment. Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R. Acta Trop; 2013 Aug 15; 127(2):101-4. PubMed ID: 23583863 [Abstract] [Full Text] [Related]
18. Rat liver nuclear nifurtimox nitroreductase activity. de Toranzo EG, Herrera DM, Castro JA. Res Commun Mol Pathol Pharmacol; 1997 Dec 15; 98(3):249-54. PubMed ID: 9485519 [Abstract] [Full Text] [Related]
19. Sister-chromatid exchange in spleenic lymphocytes of mice after exposure to nifurtimox or benznidazole. Gorla NB. Mutat Res; 1987 Jun 15; 188(2):129-33. PubMed ID: 3587260 [Abstract] [Full Text] [Related]